1. Home
  2. IMMR vs ZNTL Comparison

IMMR vs ZNTL Comparison

Compare IMMR & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immersion Corporation

IMMR

Immersion Corporation

N/A

Current Price

$7.17

Market Cap

241.4M

Sector

Technology

ML Signal

N/A

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

N/A

Current Price

$1.91

Market Cap

289.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMR
ZNTL
Founded
1993
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
241.4M
289.0M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
IMMR
ZNTL
Price
$7.17
$1.91
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
★ $7.44
AVG Volume (30 Days)
377.5K
★ 1.3M
Earning Date
09-14-2026
11-09-2026
Dividend Yield
★ 4.11%
N/A
EPS Growth
N/A
★ 18.03
EPS
★ 0.17
N/A
Revenue
★ $35,013,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$42.76
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$5.25
$1.21
52 Week High
$8.05
$6.95

Technical Indicators

Market Signals
Indicator
IMMR
ZNTL
Relative Strength Index (RSI) 47.53 29.54
Support Level $7.03 N/A
Resistance Level $7.64 $2.76
Average True Range (ATR) 0.17 0.17
MACD 0.01 -0.00
Stochastic Oscillator 53.68 5.88

Price Performance

Historical Comparison
IMMR
ZNTL

About IMMR Immersion Corporation

Immersion Corp is a licensing company focused on the acceleration, and scaling, through licensing, of haptic technologies that allow people to use sense of touch to engage with products and experience the digital world around them. Its patents cover a wide range of digital technologies and ways in which touch-related technology can be incorporated into and between hardware products and components, systems software, application software, and digital content. It operates in two operating segments: Immersion and Barnes & Noble Education. The majority of revenue is derived from Barnes & Noble Education segment which is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: